The Commission is set to update legislation on genetic engineering of crops, with its proposal to be presented in July. There will be opposition from environmental groups that want the 2001 blanket ban to be retained
As it gets easier to engineer deadly pathogens, the International Biosecurity and Biosafety Initiative for Science wants tighter controls on custom-order DNA companies, and an end to the current ‘checkbox’ approach to lab safety
The University of Amsterdam (UvA)’s Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund Macrobian Biotech BV, a single asset biotech company that will further develop medicine for the treatment of Parkinson’s disease.
With ELIXIR, the European Life Sciences Infrastructure for Biological Information, fifteen European countries have established a secure hub-and-node infrastructure in which biological data will be permanently accessible for research.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.